Nantahala Capital Management’s AYTU BioPharma AYTU Stock Holding History

Nantahala Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Hold	1,086,812	–	–	0.08%	132
2026 Q1	$2.97M	Hold	1,086,812	–	–	0.11%	121
2025 Q4	$2.83M	Hold	1,086,812	–	–	0.09%	125
2025 Q3	$2.04M	Hold	1,086,812	–	–	0.07%	133
2025 Q2	$2.37M	Hold	1,086,812	–	–	0.09%	121
2025 Q1	$1.3M	Hold	1,086,812	–	–	0.05%	116
2024 Q4	$1.85M	Hold	1,086,812	–	–	0.08%	110
2024 Q3	$2.55M	Hold	1,086,812	–	–	0.13%	93
2024 Q2	$3.17M	Hold	1,086,812	–	–	0.19%	78
2024 Q1	$3.3M	Hold	1,086,812	–	–	0.19%	78
2023 Q4	$3.09M	Hold	1,086,812	–	–	0.18%	81
2023 Q3	$2.93M	Hold	1,086,812	–	–	0.25%	77
2023 Q2	$1.74M	Buy	1,086,812 +815,217	+300%	+$1.6M	0.17%	81
2023 Q1	$608K	Buy	+271,595	New	+$795K	0.05%	102

Other funds holding AYTU

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Nantahala Capital Management's AYTU Position: Q2 2026 in Review

Nantahala Capital Management held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 1,086,812 shares worth $2.34M. The position accounts for 0.08% of the portfolio, ranked #132.

Nantahala Capital Management first reported a position in AYTU in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.3M in Q1 2024. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

Nantahala Capital Management held 1,086,812 shares of AYTU BioPharma worth $2.34M as of Q2 2026.
Nantahala Capital Management left its AYTU BioPharma share count unchanged in Q2 2026.
AYTU BioPharma made up 0.08% of Nantahala Capital Management's portfolio in Q2 2026, its #132 holding.
Nantahala Capital Management first reported a position in AYTU BioPharma in Q1 2023 and has held it in 14 quarters since.
Nantahala Capital Management's AYTU BioPharma position peaked at $3.3M in Q1 2024.
38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.